Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02482389 · ClinicalTrials.gov registry record · NA

Study of Preoperative Boost Radiotherapy

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT02482389 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02482389, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

This protocol seeks to utilize a novel method of tumor bed boost delivery and to better understand breast cancer radiation response through the analysis of pre-and post-radiation breast tumor samples.

Interventions

  • RADIATION Single fraction of 7 Gy

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2015-09-08
Est. Completion 2021-06-25
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02482389

The ClinicalTrials.gov registry entry for NCT02482389 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Single fraction of 7 Gy is the first listed.

NCT02482389 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02482389 about?

NCT02482389 is a clinical study titled "Study of Preoperative Boost Radiotherapy". This protocol seeks to utilize a novel method of tumor bed boost delivery and to better understand breast cancer radiation response through the analysis of pre-and post-radiation breast tumor samples.

What is the current status of trial NCT02482389?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-09-08. Estimated completion is 2021-06-25.

What interventions are being tested in trial NCT02482389?

The interventions under investigation include: Single fraction of 7 Gy (RADIATION).

Who is sponsoring clinical trial NCT02482389?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.